Orthrexo NDC 72835-333

NDC codes

FDA NDC Directory

Product NDC (as listed)72835-333Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72835-0333Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72835-333-02	72835033302	1 KIT in 1 CARTON (72835-333-02) * 1 BOTTLE in 1 CARTON (65162-911-74) / 150 mL in 1 BOTTLE * 85 g in 1 TUBE (51824-105-03)Marketed from Apr 2, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Orthrexo
Generic name (nonproprietary): diclofenac sodium and menthol, methyl salicylate
Dosage form: Kit
Labeler: V2 Pharma, LLC
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Apr 2, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 72835-333_007b9a39-1c4b-4d92-b007-726f888bffe8SPL ID 007b9a39-1c4b-4d92-b007-726f888bffe8SPL set ID eb070904-4f6f-42c0-981d-8dc850040185RxCUI 311498, 857700UPC 0365162911749

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N472835033302 followed by a unit qualifier and the quantity

Package 72835-0333-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 2, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Diclofenac sodium topical solution is indicated for the treatment of signs and symptoms of osteoarthritis of the knee(s). Diclofenac sodium topical solution is a nonsteroidal anti-inflammatory drug indicated for the treatment of signs and symptoms of osteoarthritis of the knee(s). ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)